Case Study  ·  Technology Monitoring

Tracking new science on cannabinoids.

A global cannabinoid company needed to keep up with fast moving research on cannabinoids and terpenes. We screened new publications, trials, grants and startups every month and profiled the findings that mattered.

The Client

The client is a global cannabinoid company. It wanted a steady view of new science and competitor moves on its compounds of interest.

The Challenge

Constant new data.
Catch what matters.

Prescouter was asked to review new publications, clinical trials, grants and startups on cannabinoids and terpenes each month, classify them, flag relevant findings and update earlier compound reports.

  • Science

    New publications

    Fresh findings each month.

  • Trials

    Clinical trials

    Studies moving toward the clinic.

  • Market

    Grants and startups

    Funding and new competitor activity.

Our Approach

Turning a flood of papers into a monthly signal.

Monthly scan
Monthlyupdate cadence

Gather new activity

Each month we collected new publications, clinical trials, grants and startups on target compounds.

Relevance scoring
Scoredentries by client interest

Classify every entry

Entries were classified against the client’s interests so the most relevant ones rose to the top.

Deep profiles
Highpriority entries profiled

Profile the best

Entries scored as high were profiled with key takeaways for the client team.

The Outcome

A monthly view of science and rivals.

Prescouter delivered monthly updates on new publications, clinical trials, grants and startup activity, classified by client interest and profiled when scored high. Each round included a spreadsheet matrix, slides and a report with key conclusions, plus insight on competitors.

  • Updates

    Monthly rounds

    A fresh view of the latest developments.

  • Profiles

    High scoring entries

    Profiled with key takeaways.

  • Rivals

    Competitor insight

    Activity tracked alongside the science.

In fast moving fields, last year’s report ages quickly. A steady monitoring rhythm keeps decisions tied to the latest evidence.

Let’s Talk

What new science could shift your pipeline?

Tell us what you need to track and we will keep you current. Wherever you’re starting from, we’ll help you get there.

Or email [email protected]

Book a Session

Want to skip the email back-and-forth?

Pick a time on our calendar right now.

If you’d like to know the outcome of your submission, please leave your email address